Temporal and Spatial Distribution of the Cannabinoid Receptors (CB1, CB2) and Fatty Acid Amide Hydroxylase in the Rat Ovary
Version of Record online: 17 MAY 2010
Copyright © 2010 Wiley-Liss, Inc.
The Anatomical Record
Volume 293, Issue 8, pages 1425–1432, August 2010
How to Cite
Bagavandoss, P. and Grimshaw, S. (2010), Temporal and Spatial Distribution of the Cannabinoid Receptors (CB1, CB2) and Fatty Acid Amide Hydroxylase in the Rat Ovary. Anat Rec, 293: 1425–1432. doi: 10.1002/ar.21181
- Issue online: 22 JUL 2010
- Version of Record online: 17 MAY 2010
- Manuscript Accepted: 23 DEC 2009
- Manuscript Revised: 23 NOV 2009
- Manuscript Received: 16 AUG 2009
- University Research Council of Kent State University
- cannabinoid receptors;
- corpus luteum
Although the effects of Δ9-tetrahydrocannabinol (THC) on ovarian physiology have been known for many decades, its mechanism of action in the rat ovary remains poorly understood. The effects of THC and endocannabinoids on many cell types appear to be mediated through the G-protein-coupled CB1 and CB2 receptors. Evidence also suggests that the concentration of the endocannabinoid anandamide is regulated by cellular fatty acid amide hydrolase (FAAH). Therefore, we examined the rat ovary for the presence of CB1 and CB2 receptors and FAAH. The CB1 receptor was present in the ovarian surface epithelium (OSE), the granulosa cells of antral follicles, and the luteal cells of functional corpus luteum (CL). The granulosa cells of small preantral follicles, however, did not express the CB1 receptor. Western analysis also demonstrated the presence of a CB1 receptor. In both preantral and antral follicles, the CB2 receptor was detected only in the oocytes. In the functional CL, the CB2 receptor was detected in the luteal cells. FAAH was codistributed with CB2 receptor in both oocytes and luteal cells. FAAH was also present in the OSE, subepithelial cords of the tunica albuginea (TA) below the OSE, and in cells adjacent to developing preantral follicles. Western analysis also demonstrated the presence of FAAH in oocytes of both preantral and antral follicles. Our observations provide potential explanation for the effects of THC on steroidogenesis in the rat ovary observed by earlier investigators and a role for FAAH in the regulation of ovarian anandamide. Anat Rec 293:1425–1432, 2010. © 2010 Wiley-Liss, Inc.
Although the mechanism of signal transduction by cannabinoids is only now being teased out, the effects of Δ9-tetrahydrocannabinol (THC) on female reproductive system have been known for decades. THC affects prenatal development (Dalterio and Bartke, 1981; Rosenkrantz et al., 1986; Abel et al., 1987), secretion of gonadotropins (Asch et al., 1979; Smith et al., 1979; Dalterio et al., 1983; Mendelson et al., 1986) and progesterone (Almirez et al., 1983), and menstrual cycle (Asch et al., 1981; Smith et al., 1983). In the ovary, THC has been shown to inhibit follicular steroidogenesis both in vivo (Zoller, 1985) and in vitro (Burstein et al., 1979; Moon et al., 1982; Reich et al., 1982; Lewysohn et al., 1984). It is now known that similar to THC, the endocannabinoid anandamide also causes a decrease in serum LH, prolactin, and progesterone, as well as an increase in stillbirths in the pregnant rat (Wenger et al., 1997). One major signal transduction pathway for THC and the endocannabinoids is via the G-protein-coupled CB1 and CB2 receptors (Howlett and Mukhopadhyay, 2000). Over a decade ago, the CB1 receptor mRNA has been shown to be present in the human ovary (Galiegue et al., 1995). Recently, the presence of both CB1 and CB2 receptors as well as anandamide and its biosynthetic enzyme N-acylphosphatidylethanolamine-phospholipase D and the degrading enzyme fatty acid amide hydrolase (FAAH) has been demonstrated in the human ovary (El-Talatini et al., 2009). An earlier study also demonstrated the presence of anandamide in the human follicular fluid (Schuel et al., 2002). Thus, potential for endocannabinoid signaling exists in the ovary. In fact, recent review articles have drawn attention to the importance of the endocannabinoid system in mammalian reproductive function (Taylor et al., 2007; Battista et al., 2008; Maccarrone, 2009). However, presently it is not known if any member of the endocannabinoid signaling system is present in the ovary of other mammals in addition to human. Therefore, we sought to determine if the G-protein-coupled cannabinoid receptors CB1 and CB2 and the anandamide-degrading enzyme FAAH are present in the rat ovary. Our data demonstrate that the components of the endocannabinoid signaling system are indeed expressed differentially in time and space in specific cell types of the rat ovary.
MATERIALS AND METHODS
All of the experiments described in this study conform to the guide for the care and use of laboratory animals, published by the National Research Council (Publications No. 0-309-05377-3, 1996) and were approved by the Kent State University Animal Care and Use Committee.
Twenty-two to twenty-five day old immature female Sprague-Dawley rats were injected subcutaneously with 15 international units (IU) of pregnant mare's serum gonadotropin (PMSG; Sigma-Aldrich, St. Louis, MO) in 100 μL of phosphate buffered saline (PBS) containing 0.2% (w/v) bovine serum albumin (BSA) or PBS alone (control). Two days later, PBS-treated rats and some of the PMSG-treated rates were sacrificed. The remaining PMSG-treated rats were injected with 5 IU of human chorionic gonadotropin (hCG) (Sigma-Aldrich, St. Louis, MO) in 100 μL of PBS-BSA. PMSG-treated preovulatory follicles ovulate in response to hCG and subsequently luteinize to form the corpora lutea of pseudopregnancy. The animals were sacrificed at three separate times after PMSG injection: (a) when preovulatory follicles are present (48 hr after PMSG), (b) 4, and (c) 14 days after hCG injection. The ovaries were removed and processed for immunofluorescent localization and Western analysis of CB1 receptor and FAAH as described below. Observations were made from ovaries obtained from at least three animals at each time point. The cerebellum and liver were also removed for use as positive controls for CB1 receptor and FAAH, respectively, in Western analysis. In addition, both FAAH wild-type and knockout mouse liver were obtained from Dr. Benjamin Cravatt of the Scripps Research Institute.
Tissue Processing and Immunoflurorescence Microscopy
The ovaries were frozen fresh in O.C.T. compound (Lab-Tek Products, Naperville, IL) and 8-μm thick sections were cut in a cryostat set at −15°C. Immunostaining was performed as before with minor modifications (Bagavandoss, 1998). Briefly, the sections were fixed in cold acetone for 10 min and air-dried. Subsequently, the sections were washed in PBS-0.2% BSA-0.05% Tween 20 (PBST) and incubated for 2 hr at 25°C or overnight at 4°C with following rabbit polyclonal antibodies in PBST ± blocking peptides: CB2 antibody prepared against residues 20–33 of human CB2 receptor (Cayman Chemicals, Ann Arbor, MI) at 5 μg/mL; CB1 antibody prepared against residues 400–460 of the human CB1 receptor (Dr. Ken Mackie, Indiana University, Bloomington) at 1:200 dilution; FAAH antibody prepared against residues 33–579 of rat FAAH enzyme (Dr. Benjamin Cravatt, Scripps Research Institute, San Diego) at 1:250 dilution. After three 5-min washes in PBST, the sections were incubated with fluorescein isothiocyanate (FITC) or rhodamine isothiocyanate (TRITC)-conjugated secondary antibodies (Organon Teknika Corporation, Durham, NC) for 30–40 minutes at 25°C, washed and mounted in Vectashield® mounting medium (Vector laboratories, Burlingame, CA).
For double labeling, sections were simultaneously incubated with FAAH or cannabinoid receptor antibody and a guinea pig polyclonal antibody (Reed et al., 1993) prepared against rat type I interstitial collagen at 1:50 dilution. Subsequently, the sections were washed as above and incubated simultaneously with FITC-goat anti-rabbit and TRITC goat anti-guinea pig secondary antibodies, rinsed in PBST and mounted as above. The sections were viewed and photographed using an Olympus inverted microscope equipped with Olympus FluoView, three-laser confocal microscopy system.
The PMSG-primed ovaries, liver, and the cerebellum were homogenized in buffer (Plet et al., 1982) containing tris(hydroxymethyl) aminomethane hydrochloride (Tris-HCl 20 mM, pH 7.5), sucrose (0.25 M), MgCl2 (2.5 mM), EDTA (2.5 mM), KCl (10 mM), thimerosal (0.02%), and a protease inhibitor cocktail (Sigma-Aldrich, MO). The homogenate was centrifuged for 10 min at 800 g; the supernatant was collected and centrifuged again at 20,000 g for 20 min. Oocytes were isolated from PMSG-injected rat ovaries (Mehlmann and Kline, 1994) and dissolved in 0.25% octylglucoside containing protease inhibitors. Equal amounts of reduced proteins (∼200 μg/lane) were separated on 10% SDS-polyacrylamide gel. The proteins were then transferred to a polyvinylidene fluoride membrane and blocked overnight at 4°C in PBS containing nonfat dry milk (5%), Tween-20 (0.05%), and magnesium chloride (2.5 mM). The blots were incubated overnight at 4°C with an affinity purified rabbit polyclonal antibody (1:300 dilution) prepared against GST fusion protein containing the first 77 amino terminal residues (GST-CB1:1–77) of the CB1 receptor (Twitchell et al., 1997). Western blot against FAAH was performed with a rabbit polyclonal antibody raised against rat residues 561–579 of FAAH (Cayman Chemicals, Ann Arbor) at 1:250 dilution. The membrane was washed in PBST and the bound antibody was probed with an enhanced chemiluminescent detection kit (Amersham Biosciences, NJ). Control blots were incubated with the primary antibody, which was preincubated with 2 μg of the blocking peptide for 1 hr at room temperature.
Distribution of CB1 Receptor
The CB1 receptor distinctly localizes to the plasma membrane of granulosa cells (Fig. 1A, B). Although the receptors are present in the granulosa cells of antral follicles, none is present in the granulosa cells of the preantral follicles (Fig. 1A, B). CB1 receptor is also not present in oocytes or thecal cells (Fig. 1A, B). In 4-day old corpus luteum (CL), which secretes increasing concentrations of progesterone, CB1 receptor is expressed by the luteal cells (Fig. 1C). During this time, the granulosa cells of the follicles continue to show staining for the CB1 receptor (Fig. 1C). The ovarian surface epithelium (OSE) is also immunoreactive to the CB1 receptor antibody (Fig. 1D). The red counterstaining with interstitial collagen antibody shows the wide distribution of this collagen throughout the ovary (Fig. 1A–C). Note the distinct localization of this collagen in the reticular layer (Bagavandoss et al., 1983) of the basal lamina (Fig. 1B, arrows).
Distribution of CB2 and FAAH
Unlike the CB1 receptor, CB2 receptor is not present in the granulosa cells of the follicles. CB2 receptor is expressed exclusively by the oocytes of both preantral and antral follicles (Fig. 2A). FAAH antibody also stains the oocytes in the follicles (Fig. 2B, C). Even in the preovulatory follicles FAAH localization remains confined to the oocyte without any reactivity in the surrounding cumulus cells (Fig. 2C). Similar to CB2, thecal and granulosa cells do not show any immunoreactivity for FAAH antibody. However, strong FAAH immunoreactivity is present in the OSE (Fig. 2D, 3A) and in individual cells and subepithelial cords of the tunica albuginea (TA) below the OSE (Fig. 2D, 3A). Many FAAH-positive cells are scattered throughout the cortex below the TA and adjacent to developing preantral follicles (Fig. 3A, B).
In day 4 progesterone secreting CL, the luteal cells stain strongly for both FAAH (Fig. 4A) and CB2 (Fig. 4B). FAAH staining is also observed in the interstitium (Fig 4A). By 14th day of pseudopregnancy, when the CL is undergoing regression, staining for both FAAH (Fig 4C) and CB2 (Fig. 4D) are drastically reduced in the luteal cells. However, the interstitial cells and the oocytes continue to remain positive for both FAAH (Fig. 4C) and CB2 (Fig. 4D), respectively.
Western blot of CB1 and FAAH
A Mr 60 kDa CB1 receptor was present both in the PMSG primed ovary and in the cerebellum (Fig. 5A), which served as a positive control (Tsou et al., 1998). The binding is specific as preabsorption of the antibody with the blocking peptide selectively abolished the Mr 60 kDa CB1 band (Fig. 5B). The antibody also binds to a Mr 96 kDa protein, which is not blocked by the blocking peptide (Fig. 5A, B). Western analyses of FAAH in the oocytes show that the antibody, in addition to staining the expected Mr 60 kDa FAAH protein in both the rat and wild-type mouse livers (positive control), stains a nonspecific Mr 76 kDa protein (Fig. 5C). Specificity of the antibody is shown by the absence of Mr 60 kDa FAAH staining in the FAAH knockout mouse liver (Fig. 5C).
Using an established immature rat model for follicular development and CL formation (Bagavandoss, 1998), we have studied the presence of cannabinoid receptors CB1 and CB2 as well as FAAH, the major enzyme that regulates the concentration of the endocannabinoid anandamide in cells (Mckinney and Cravatt, 2005). In this model, within 48 hours after PMSG injection, many follicles develop into preovulatory follicles. Subsequently, in response to hCG, pseudopregnancy begins as the follicles ovulate and transform into CL. By fourth day of pseudopregnancy, the CL is highly steroidogenic and secretes increasing amount of progesterone (Horikoshi and Wiest, 1971). By 14th day, however, the ephemeral CL predictably shows marked decline in progesterone secretion and undergoes structural involution and regression. Therefore, this animal model is well suited for studying the distribution of biomolecules during follicular and luteal phases of the ovary.
The results of our study demonstrate the differential expression of both cannabinoid receptors and FAAH during different stages of ovarian function. During follicular development, CB1 receptor is present only in the antral follicles of granulosa cells. It is known that though the development of preantral follicles is not dependent upon gonadotropins, subsequent antral development requires FSH and estradiol (Robker and Richards, 1998 and references therein). Therefore, the appearance of CB1 receptor in the antral follicles suggests that these receptors are induced in response to FSH-like activity of PMSG.
Unlike the CB1 receptor, CB2 receptor is not present in the granulosa cells during any stage of follicular development. Furthermore, CB2 receptor is restricted to the oocytes of both preantral and antral follicles. The differential distribution of CB1 and CB2 receptors in the follicle suggests that during follicular development ovarian anandamide (Schuel et al., 2002, El-Talatini et al., 2009) will simultaneously act on two distinct cell types through two distinct cannabinoid receptors. During pseudopregnancy, both cannabinoid receptors are concurrently present in the functional luteal cells but not in the cells of regressing CL.
Recently, during the preparation of this manuscript, both CB1 and CB2 receptors have been demonstrated in the adult human ovary (El-Talatini et al., 2009). Here too, CB1 receptor is expressed primarily in the large antral follicles and the functioning CL with less intense expression in small follicles and corpus albicans. However, some expression was also observed in the oocyte and theca. Similar to our study, CB2 receptor was observed in the oocytes of both preantral and antral follicles. However, unlike in our study, granulosa cells of the human follicles were also shown to express CB2 receptor (El-Talatini et al., 2009). In our study, we have used immunofluorescence, whereas the study on human ovaries was conducted with biotinylated secondary antibody and ABC Elite Reagent (El-Talatini et al., 2009). Therefore, it is not clear if these observed differences reflect from differences between species or differences in methodology.
Both CB1 (Devane et al., 1988; Matsuda et al., 1990) and CB2 receptors (Munro et al., 1993) are G-protein-coupled receptors. THC and the endocannabinoids anandamide and 2-AG activate both these receptors (Howlett and Mukhopadhyay, 2000 and references therein). Activation of these receptors results in multiple signal transduction mechanisms, including the inhibition of adenylyl cyclase and consequent decrease in cAMP (Matsuda et al., 1990; Felder et al., 1992; Vogel et al., 1993) or stimulation of adenylyl cyclase and corresponding increase in cAMP (Glass and Felder, 1997; Rodriguez de Fonseca et al., 1999). In fact, in rat granulosa cell cultures, THC has been shown to inhibit LH-stimulated cAMP and progesterone production (Lewysohn et al., 1984). Cannabinoids also inhibit both basal and FSH-stimulated progesterone production in granulosa cells (Moon et al., 1982). In rat luteal cells too cannabinoids have been shown to inhibit steroidogenesis (Burstein et al., 1979). Thus, in granulosa and luteal cells potential exists for cross talk between signal transduction pathways generated by gonadotropins and endocannbinoids.
FAAH regulates the concentration of anandamide by metabolizing it into arachidonic acid and ethanolamide (McKinney and Cravatt, 2005). Both FAAH and CB2 receptor are concurrently present in the oocytes of preantral and antral follicles. The consequences of such presence are two-fold: One, by decreasing the concentration of anandamide, FAAH could potentially regulate the availability of anandamide to the CB2 receptor. Two, FAAH-generated arachidonic acid itself could serve as a signal or a substrate for additional cellular signaling in follicles, including the oocyte. In fact, arachidonic acid has been shown to be a constituent of mammalian oocytes (Homa et al., 1986; Matorras et al., 1998; McEvoy et al., 2000; Kim et al., 2001). Further, the presence of FAAH in the oocyte invokes additional possibilities for follicular maturation. For example, oocyte maturation and cumulus expansion require both cyclooxygenase 2 (COX-2) and prostaglandin E2 (Takahashi et al., 2006). However, COX-2 is expressed only by the cumulus cells not the oocyte (Dell'Aquila et al., 2004; Takahashi et al., 2006; Feuerstein et al., 2007). Thus, FAAH-generated arachidonic acid from the oocyte could serve as a major substrate for COX-2 in the neighboring cumulus cells for the production of prostaglandin. The presence of both FAAH and CB receptors in the CL also suggests the existence of regulated cannabinoid-mediated signaling in the luteal cells. For example, arachidonic acid generated from the luteal cell FAAH could affect the production of progesterone by the CL as arachidonic acid itself has been shown to stimulate progesterone production in the rat luteal cells (Wang and Leung, 1988).
The presence of FAAH and CB1 receptor in the OSE is quite intriguing. As the OSE is a major source of ovarian cancer, potential exists for cannabinoid signaling in ovarian carcinogenesis. FAAH was also present in the OSE-associated crypts, subepithelial cords of the tunica albuginea, and in the cells scattered in the ovarian cortex. It is not clear if these FAAH positive cells in the ovarian cortex migrate from the OSE or from the subepithelial cords and contribute to any cells during follicular development. Results from human, sheep, and mouse suggest such a possibility. Data from an elegant study in the adult human ovary indicate that the OSE and the subepithelial cords in the TA constitute a dynamic population of cells capable of differentiating into presumptive granulosa or germ cells (Bukovsky et al., 2004). In the fetal sheep ovary, it has been recently suggested that greater than 95% of the granulosa cells in the newly formed primordial follicles originate from the OSE (Sawyer et al., 2002). In the adult mouse ovary at least some of the cells in OSE appear to be the source of stem cells (Johnson et al., 2004). If OSE does contribute to other parenchymal cells of the rat ovary, we suggest that FAAH might serve as a potential marker for tracking the cells of the OSE. In summary, results of our study show both the presence and differential distribution of CB1 and CB2 cannabinoid receptors and the anandamide-metabolizing enzyme FAAH in the rat ovary. Therefore, potential exists for the regulation of ovarian physiology by the endocannabinoid system.
The authors are grateful to Dr. Ken Mackie of the Indiana University, Bloomington for his generous provision of CB1 receptor antibodies, blocking peptides and valuable suggestions and Dr. Benjamin Cravatt of Scripps Research Institute for providing the FAAH antibody and protein samples from wild and FAAH knockout mice. The type I collagen antibody was kindly provided by Dr. Helene Sage of Hope Heart Institute, Seattle. We are also thankful to Drs. Bruot, Kline, and Vijayaraghavan for sharing their laboratory facility.
- 1987. Effects of delta 9-tetrahydrocannabinol, phenobarbital, and their combination on pregnancy and offspring in rats. Teratology 36: 193–198. , , .
- 1983. The effects of marijuana extract and delta Δ9-tetrahydrocannabinol on luteal function in the rhesus monkey. Fertil Steril 39: 212–217. , , .
- 1979. Acute decreases in serum prolactin concentrations caused by Δ9-tetrahydrocannabinol in nonhuman primates. Fertil Steril 32: 571–575. , , , .
- 1981. Effects of Δ9-tetrahydrocannabinol during the follicular phase of the rhesus monkey (Macaca mulatta). J Clin Endocr Metab 52: 50–55. , , , .
- 1983. Developmental changes in the ovarian follicular basal lamina detected by immunofluorescence and electron microscopy. J Histochem Cytochem 31: 633–640. , , .
- 1998. Differential distribution of gelatinases and tissue inhibitor of metalloproteinase-1 in the rat ovary. J Endocrinol 158: 221–228. .
- 2008. Interplay between endocannabinoids, steroids and cytokines in the control of human reproduction. J Neuroendocrinol 20( Suppl 1): 82–89. , , , .
- 2004. Origin of germ cells and formation of new primary follicles in adult human ovaries. Reprod Biol Endocrinol 2: 20. , , , .
- 1979. Cannabinoid inhibition of rat luteal cell progesterone synthesis. Res Commun Chem Path 24: 413–416. , , .
- 1981. Fetal testosterone in mice: effect of gestational age and cannabinoid exposure. J Endocrinol 91: 509–514. , .
- 1983. Effects of Δ9-THC on plasma hormone levels in female mice. Subs Alco Act Misuse 4: 339–345. , , .
- 2004. Cumulus expansion, nuclear maturation and connexin 43, cyclooxygenase-2 and FSH receptor mRNA expression in equine cumulus-oocyte complexes cultured in vitro in the presence of FSH and precursors for hyaluronic acid synthesis. Reprod Biol Endocrinol 2: 44; Doi:10.1186/1477-7827-2-44. , , , , , , , .
- 1988. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34: 605–613. , , , , .
- 2009. Localisation and function of the endocannabinoid system in the human ovary. PLoS ONE 4: e4579; Doi:10.1371/journal.pone.0004579. , , , , , .
- 1992. Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol Pharmacol 42: 838–845. , , , , .
- 2007. Gene expression in human cumulus cells: one approach to oocyte competence. Human Reprod 22: 3069–3077. , , , , , .
- 1995. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232: 54–61. , , , , , , , , , .
- 1997. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci 17: 5327–5333. , .
- 1986. Lipid analysis of immature pig oocytes. J Reprod Fertil 77: 425–434. , , .
- 1971. Interrelationship between estrogen and progesterone secretion and trauma-induced deciduomata. On causes of uterine refractoriness in the “Parlow Rat.” Endocrinology 89: 807–817. , .
- 2000. Cellular signal transduction by anandamide and 2-arachidonoylglycerol. Chem Phys Lipids 108: 53–70. , .
- 2004. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 428: 145–150. , , , , .
- 2001. Lipid and fatty acid analysis of fresh and frozen-thawed immature and in vitro matured bovine oocytes. Reproduction 122: 131–138. , , , .
- 1984. The suppressive effect of delta-1-tetrahydrocannabinol on the steroidogenic activity of rat granulosa cells in culture. Horm Res 19: 43–51. , , , .
- 2009. Endocannabinoids: friends and foes of reproduction. Prog Lipid Res 48: 344–354. .
- 1990. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561–564. , , , , .
- 1998. Fatty acid composition of fertilization-failed human oocytes. Hum Reprod 13: 2227–2230. , , , , , .
- 2000. Fatty acid composition of lipids in immature cattle, pig and sheep oocytes with intact zona pellucida. J Reprod Fertil 118: 163–170. , , , , .
- 2005. Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 74: 411–432. , .
- 1994. Regulation of intracellular calcium in the mouse egg: calcium release in response to sperm or inositol trisphosphate is enhanced after meiotic maturation. Biol Reprod 51: 1088–1098. , .
- 1986. Marihuana smoking suppresses luteinizing hormone in women. J Pharmacol Exp Ther 237: 862–866. , , , , , .
- 1982. Effect of cannabinoids on progesterone production by ovarian granulosa cells of the pig and rat. Life Sci 31: 315–318. , , .
- 1993. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61–65. , , .
- 1982. Effect of retinoic acid treatment of F9 embryonal carcinoma cells on the activity and distribution of cyclic AMP-dependent protein kinase. J Biol Chem 257: 889–893. , , .
- 1993. Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization. J Histochem Cytochem 41: 1467–1477. , , , , , .
- 1982. In vitro effects of cannabinoids on follicular function in the rat. Biol Reprod 27: 223–231. , , , , , .
- 1998. Hormone-induced proliferation and differentiation of granulosa cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1. Mol Endocrinol 12: 924–940. , .
- 1999. Effects of Δ9-THC on VIP-induced prolactin secretion in anterior pituitary cultures: evidence for the presence of functional cannabinoid CB1 receptors in pituitary cells. Brain Res 841: 114–122. , , , .
- 1986. Marihuana-induced embryotoxicity in the rabbit. Fund Appl Toxicol 7: 236–243. , , , .
- 2002. Formation of ovarian follicles during fetal development in sheep. Biol Reprod 66: 1134–1150. , , , , , .
- 2002. N-Acylethanolamines in human reproductive fluids. Chem Phys Lipids 121: 211–227. , , , , , , .
- 1979. Effect of tetrahydrocannabinol on the hypothalamic-pituitary axis in the ovariectomized rhesus monkey. Fertil Steril 31: 335–339. , , , .
- 1983. Tolerance develops to the disruptive effects of Δ9-tetrahydrocannabinol on primate menstrual cycle. Science 219: 1453–1455. , , , .
- 2006. Cyclooxygenase-2-derived prostaglandin E2 directs oocyte maturation by differentially influencing multiple signaling pathways. J Biol Chem 281: 37117–37129. , , , .
- 2007. The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy. Hum Reprod Update 13: 501–513. , , , .
- 1998. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83: 393–411. , , , , .
- 1997. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol 78: 43–50. , , .
- 1993. Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J Neurochem 61: 352–355. , , , , , .
- 1988. Role of arachidonic acid in luteinizing hormone-releasing hormone action: stimulation of progesterone production in rat granulosa cells. Endocrinology 122: 906–911. , .
- 1997. Effects of anandamide on gestation in pregnant rats. Life Sci 60: 2361–2371. , , , , .
- 1985. Effects of tetrahydrocannabinol on rat preovulatory follicles: a quantitative cytochemical analysis. Histochem J 17: 1347–1358. .